CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY

This adverse event was reported 1438 times

These drugs are most commonly taken by patients reporting CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY:

# Drug Count
0 HUMAN IMMUNOGLOBULIN G 349
1 PREDNISONE 115
2 MYCOPHENOLATE MOFETIL 89
3 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 89
4 PREDNISOLONE 89
5 PREDNISOLONE ORAL 89
6 PREDNISOLONE ORAL SOLUTION 89
7 ADALIMUMAB 88
8 TACROLIMUS 69
9 RITUXIMAB 60
See all common drugs associated with CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY

CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 22 0.0454
1 HUMAN IMMUNOGLOBULIN G 349 0.0167
2 EFGARTIGIMOD ALFA 20 0.0050
3 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 17 0.0042
4 AZATHIOPRINE SODIUM 6 0.0024
5 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 13 0.0020
6 BRENTUXIMAB VEDOTIN 18 0.0017
7 ERGOCALCIFEROL 43 0.0014
8 BUSULFAN 23 0.0014
9 RITUXIMAB-ABBS 7 0.0014
See all drugs enriched for association with CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY